Serum Neurofilament Light Chain: A Marker of Nervous System Damage in Myopathies

Purpose: Neurofilament light chain in serum (sNfL) has been suggested as a biomarker for the assessment of neuroaxonal damage. Since NfL are not expressed in muscle, elevated sNfL in patients with primary myopathies suggest additional nervous system involvement. To verify this hypothesis, we measure...

Descripción completa

Detalles Bibliográficos
Autores principales: Saak, Annika, Benkert, Pascal, Akgün, Katja, Willemse, Eline, Kuhle, Jens, Ziemssen, Tjalf, Jackson, Sandra, Schaefer, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718922/
https://www.ncbi.nlm.nih.gov/pubmed/34975387
http://dx.doi.org/10.3389/fnins.2021.791670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718922/
https://www.ncbi.nlm.nih.gov/pubmed/34975387
http://dx.doi.org/10.3389/fnins.2021.791670

Ejemplares similares